These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 24530403
1. Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909). Minang JT, Inglefield JR, Harris AM, Lathey JL, Alleva DG, Sweeney DL, Hopkins RJ, Lacy MJ, Bernton EW. Vaccine; 2014 Nov 28; 32(50):6847-54. PubMed ID: 24530403 [Abstract] [Full Text] [Related]
9. Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax. Klinman DM, Currie D, Lee G, Grippe V, Merkel T. Microbes Infect; 2007 Oct 28; 9(12-13):1478-83. PubMed ID: 17913545 [Abstract] [Full Text] [Related]
11. Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques. Chen L, Schiffer JM, Dalton S, Sabourin CL, Niemuth NA, Plikaytis BD, Quinn CP. Clin Vaccine Immunol; 2014 Nov 28; 21(11):1512-20. PubMed ID: 25185577 [Abstract] [Full Text] [Related]
12. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice. Lv J, Zhang YY, Lu X, Zhang H, Wei L, Gao J, Hu B, Hu WW, Hu DZ, Jia N, Feng X. Biologicals; 2017 Mar 28; 46():130-138. PubMed ID: 28215694 [Abstract] [Full Text] [Related]
13. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR. J Immunol; 2003 Jun 01; 170(11):5636-43. PubMed ID: 12759444 [Abstract] [Full Text] [Related]
16. Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109. Gu M, Hine PM, James Jackson W, Giri L, Nabors GS. Vaccine; 2007 Jan 05; 25(3):526-34. PubMed ID: 16973247 [Abstract] [Full Text] [Related]
17. Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans. Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, Poland GA, Keyserling HL, El Sahly H, Jacobson RM, Marano N, Plikaytis BD, Wright JG. Clin Vaccine Immunol; 2016 Apr 05; 23(4):326-38. PubMed ID: 26865594 [Abstract] [Full Text] [Related]
18. Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart. Shearer JD, Henning L, Sanford DC, Li N, Skiadopoulos MH, Reece JJ, Ionin B, Savransky V. Vaccine; 2021 Jan 03; 39(1):1-5. PubMed ID: 33199078 [Abstract] [Full Text] [Related]
20. A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen. Gwinn WM, Johnson BT, Kirwan SM, Sobel AE, Abraham SN, Gunn MD, Staats HF. Vaccine; 2013 Mar 01; 31(11):1480-9. PubMed ID: 23352329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]